Cargando…

Utility of bronchial lavage fluids for epithelial growth factor receptor mutation assay in lung cancer patients: Comparison between cell pellets, cell blocks and matching tissue specimens

The detection of epidermal growth factor receptor (EGFR) mutations is necessary for the selection of suitable patients with non-small cell lung cancer (NSCLC) for treatment with EGFR tyrosine kinase inhibitors. Cytology specimens are known to be suitable for EGFR mutation detection, although tissue...

Descripción completa

Detalles Bibliográficos
Autores principales: Asaka, Shiho, Yoshizawa, Akihiko, Nakata, Rie, Negishi, Tatsuya, Yamamoto, Hiroshi, Shiina, Takayuki, Shigeto, Shohei, Matsuda, Kazuyuki, Kobayashi, Yukihiro, Honda, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774526/
https://www.ncbi.nlm.nih.gov/pubmed/29399190
http://dx.doi.org/10.3892/ol.2017.7464
_version_ 1783293772227936256
author Asaka, Shiho
Yoshizawa, Akihiko
Nakata, Rie
Negishi, Tatsuya
Yamamoto, Hiroshi
Shiina, Takayuki
Shigeto, Shohei
Matsuda, Kazuyuki
Kobayashi, Yukihiro
Honda, Takayuki
author_facet Asaka, Shiho
Yoshizawa, Akihiko
Nakata, Rie
Negishi, Tatsuya
Yamamoto, Hiroshi
Shiina, Takayuki
Shigeto, Shohei
Matsuda, Kazuyuki
Kobayashi, Yukihiro
Honda, Takayuki
author_sort Asaka, Shiho
collection PubMed
description The detection of epidermal growth factor receptor (EGFR) mutations is necessary for the selection of suitable patients with non-small cell lung cancer (NSCLC) for treatment with EGFR tyrosine kinase inhibitors. Cytology specimens are known to be suitable for EGFR mutation detection, although tissue specimens should be prioritized; however, there are limited studies that examine the utility of bronchial lavage fluid (BLF) in mutation detection. The purpose of the present study was to investigate the utility of BLF specimens for the detection of EGFR mutations using a conventional quantitative EGFR polymerase chain reaction (PCR) assay. Initially, quantification cycle (Cq) values of cell pellets, cell-free supernatants and cell blocks obtained from three series of 1% EGFR mutation-positive lung cancer cell line samples were compared for mutation detection. In addition, PCR analysis of BLF specimens obtained from 77 consecutive NSCLC patients, detecting EGFR mutations was validated, and these results were compared with those for the corresponding formalin-fixed paraffin-embedded (FFPE) tissue specimens obtained by surgical resection or biopsy of 49 of these patients. The Cq values for mutation detection were significantly lower in the cell pellet group (average, 29.58) compared with the other groups, followed by those in cell-free supernatants (average, 34.15) and in cell blocks (average, 37.12) for all three series (P<0.05). Mutational status was successfully analyzed in 77 BLF specimens, and the results obtained were concordant with those of the 49 matching FFPE tissue specimens. Notably, EGFR mutations were even detected in 10 cytological specimens that contained insufficient tumor cells. EGFR mutation testing with BLF specimens is therefore a useful and reliable method, particularly when sufficient cancer cells are not obtained.
format Online
Article
Text
id pubmed-5774526
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-57745262018-02-02 Utility of bronchial lavage fluids for epithelial growth factor receptor mutation assay in lung cancer patients: Comparison between cell pellets, cell blocks and matching tissue specimens Asaka, Shiho Yoshizawa, Akihiko Nakata, Rie Negishi, Tatsuya Yamamoto, Hiroshi Shiina, Takayuki Shigeto, Shohei Matsuda, Kazuyuki Kobayashi, Yukihiro Honda, Takayuki Oncol Lett Articles The detection of epidermal growth factor receptor (EGFR) mutations is necessary for the selection of suitable patients with non-small cell lung cancer (NSCLC) for treatment with EGFR tyrosine kinase inhibitors. Cytology specimens are known to be suitable for EGFR mutation detection, although tissue specimens should be prioritized; however, there are limited studies that examine the utility of bronchial lavage fluid (BLF) in mutation detection. The purpose of the present study was to investigate the utility of BLF specimens for the detection of EGFR mutations using a conventional quantitative EGFR polymerase chain reaction (PCR) assay. Initially, quantification cycle (Cq) values of cell pellets, cell-free supernatants and cell blocks obtained from three series of 1% EGFR mutation-positive lung cancer cell line samples were compared for mutation detection. In addition, PCR analysis of BLF specimens obtained from 77 consecutive NSCLC patients, detecting EGFR mutations was validated, and these results were compared with those for the corresponding formalin-fixed paraffin-embedded (FFPE) tissue specimens obtained by surgical resection or biopsy of 49 of these patients. The Cq values for mutation detection were significantly lower in the cell pellet group (average, 29.58) compared with the other groups, followed by those in cell-free supernatants (average, 34.15) and in cell blocks (average, 37.12) for all three series (P<0.05). Mutational status was successfully analyzed in 77 BLF specimens, and the results obtained were concordant with those of the 49 matching FFPE tissue specimens. Notably, EGFR mutations were even detected in 10 cytological specimens that contained insufficient tumor cells. EGFR mutation testing with BLF specimens is therefore a useful and reliable method, particularly when sufficient cancer cells are not obtained. D.A. Spandidos 2018-02 2017-11-21 /pmc/articles/PMC5774526/ /pubmed/29399190 http://dx.doi.org/10.3892/ol.2017.7464 Text en Copyright: © Asaka et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Asaka, Shiho
Yoshizawa, Akihiko
Nakata, Rie
Negishi, Tatsuya
Yamamoto, Hiroshi
Shiina, Takayuki
Shigeto, Shohei
Matsuda, Kazuyuki
Kobayashi, Yukihiro
Honda, Takayuki
Utility of bronchial lavage fluids for epithelial growth factor receptor mutation assay in lung cancer patients: Comparison between cell pellets, cell blocks and matching tissue specimens
title Utility of bronchial lavage fluids for epithelial growth factor receptor mutation assay in lung cancer patients: Comparison between cell pellets, cell blocks and matching tissue specimens
title_full Utility of bronchial lavage fluids for epithelial growth factor receptor mutation assay in lung cancer patients: Comparison between cell pellets, cell blocks and matching tissue specimens
title_fullStr Utility of bronchial lavage fluids for epithelial growth factor receptor mutation assay in lung cancer patients: Comparison between cell pellets, cell blocks and matching tissue specimens
title_full_unstemmed Utility of bronchial lavage fluids for epithelial growth factor receptor mutation assay in lung cancer patients: Comparison between cell pellets, cell blocks and matching tissue specimens
title_short Utility of bronchial lavage fluids for epithelial growth factor receptor mutation assay in lung cancer patients: Comparison between cell pellets, cell blocks and matching tissue specimens
title_sort utility of bronchial lavage fluids for epithelial growth factor receptor mutation assay in lung cancer patients: comparison between cell pellets, cell blocks and matching tissue specimens
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774526/
https://www.ncbi.nlm.nih.gov/pubmed/29399190
http://dx.doi.org/10.3892/ol.2017.7464
work_keys_str_mv AT asakashiho utilityofbronchiallavagefluidsforepithelialgrowthfactorreceptormutationassayinlungcancerpatientscomparisonbetweencellpelletscellblocksandmatchingtissuespecimens
AT yoshizawaakihiko utilityofbronchiallavagefluidsforepithelialgrowthfactorreceptormutationassayinlungcancerpatientscomparisonbetweencellpelletscellblocksandmatchingtissuespecimens
AT nakatarie utilityofbronchiallavagefluidsforepithelialgrowthfactorreceptormutationassayinlungcancerpatientscomparisonbetweencellpelletscellblocksandmatchingtissuespecimens
AT negishitatsuya utilityofbronchiallavagefluidsforepithelialgrowthfactorreceptormutationassayinlungcancerpatientscomparisonbetweencellpelletscellblocksandmatchingtissuespecimens
AT yamamotohiroshi utilityofbronchiallavagefluidsforepithelialgrowthfactorreceptormutationassayinlungcancerpatientscomparisonbetweencellpelletscellblocksandmatchingtissuespecimens
AT shiinatakayuki utilityofbronchiallavagefluidsforepithelialgrowthfactorreceptormutationassayinlungcancerpatientscomparisonbetweencellpelletscellblocksandmatchingtissuespecimens
AT shigetoshohei utilityofbronchiallavagefluidsforepithelialgrowthfactorreceptormutationassayinlungcancerpatientscomparisonbetweencellpelletscellblocksandmatchingtissuespecimens
AT matsudakazuyuki utilityofbronchiallavagefluidsforepithelialgrowthfactorreceptormutationassayinlungcancerpatientscomparisonbetweencellpelletscellblocksandmatchingtissuespecimens
AT kobayashiyukihiro utilityofbronchiallavagefluidsforepithelialgrowthfactorreceptormutationassayinlungcancerpatientscomparisonbetweencellpelletscellblocksandmatchingtissuespecimens
AT hondatakayuki utilityofbronchiallavagefluidsforepithelialgrowthfactorreceptormutationassayinlungcancerpatientscomparisonbetweencellpelletscellblocksandmatchingtissuespecimens